As the most important pharma hub in its region, and one of the most important globally, many companies look to launch new products in Singapore first…

Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and global functions across four sites in…

MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the importance of leveraging learnings…

Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines. Moreover, vaccines are an important…

While outbreaks of the devastating Ebola virus have – thankfully – generally been highly localized to West Africa, the highly infectious and…

During the fourth International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) COVID-19 media briefing, one thematic dominated:…

Top global pharma executives involved in the development of COVID-19 vaccines have stated their commitment to not rushing the release of any potential…

The top 10 pharma companies in Norway ranked by 2019 turnover according to IQVIA data. The Norwegian market is dominated by multinationals, with…

The Top 15 pharmaceutical companies in Norway ranked by sales turnover in 2019. The market is dominated by multinationals, with Novartis, Pfizer and…

US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central London, with plans to open the…

Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical powerhouses of Germany and France,…

The top 10 of Pharmaceutical Exec's Top 50 Companies 2020. Roche overtakes Pfizer to take the number one spot, followed by Novartis which moves up…